Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside

Hypertrophic cardiomyopathy (HCM), the most common inherited heart disease, is still orphan of a specific drug treatment. The erroneous consideration of HCM as a rare disease has hampered the design and conduct of large, randomized trials in the last 50 years, and most of the indications in the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Palandri, Chiara, Santini, Lorenzo, Argirò, Alessia, Margara, Francesca, Doste, Ruben, Bueno-Orovio, Alfonso, Olivotto, Iacopo, Coppini, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209358/
https://www.ncbi.nlm.nih.gov/pubmed/35696053
http://dx.doi.org/10.1007/s40265-022-01728-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209358/
https://www.ncbi.nlm.nih.gov/pubmed/35696053
http://dx.doi.org/10.1007/s40265-022-01728-w

Ejemplares similares